Overview of Reviews Protocol

Interventions for neovascular age-related macular degeneration

  1. Jennifer R Evans1,*,
  2. Gianni Virgili2,
  3. Iris Gordon1,
  4. Catey Bunce3,
  5. Usha Chakravarthy4,
  6. Parul Desai5,
  7. Astrid Fletcher6

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007650

How to Cite

Evans JR, Virgili G, Gordon I, Bunce C, Chakravarthy U, Desai P, Fletcher A. Interventions for neovascular age-related macular degeneration (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007650. DOI: 10.1002/14651858.CD007650.

Author Information

  1. 1

    London School of Hygiene & Tropical Medicine, Cochrane Eyes and Vision Group, ICEH, London, UK

  2. 2

    University of Florence, Department of Ophthalmology, Florence, Italy

  3. 3

    Moorfields Eye Hospital NHS Foundation Trust, Research and Development Department, London, UK

  4. 4

    Queen's University and Royal Victoria Hospitals, Belfast, UK

  5. 5

    Moorfields Eye Hospital NHS Foundation Trust, London, UK

  6. 6

    London School of Hygiene & Tropical Medicine, Epidemiology Unit, London, UK

*Jennifer R Evans, Cochrane Eyes and Vision Group, ICEH, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. jennifer.evans@lshtm.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To provide an overview of the benefits and harms of interventions for neovascular AMD as measured 12 months after the start of treatment.

To consider the longer term effects of these interventions (after 24 months).

To identify gaps in the evidence.